Orexigen Therapeutics, Inc. (OREX) Reaches $0.85 Yearly Low; Molina Healthcare (MOH) Sellers Decreased By 6.18% Their Shorts
Molina Healthcare Incorporated (NYSE:MOH) had a decrease of 6.18% in short interest. MOH’s SI was 9.02 million shares in February ...
Differential Brands Group Inc. (DFBG) Analysts See $0.05 EPS; FERGUSON PLC ADRS SPONSORED (FERGY) Sellers Decreased By 48.67% Their Shorts
FERGUSON PLC ADRS SPONSORED (OTCMKTS:FERGY) had a decrease of 48.67% in short interest. FERGY’s SI was 48,300 shares in February ...
Check-Cap Ltd. (CHEK) Analysts See $-0.14 EPS; Allegheny Technologies (ATI) Covered By 8 Bullish Analysts Last Week
Among 13 analysts covering Allegheny Tech (NYSE:ATI), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. ...
As Westmoreland Coal Co (WLB) Share Value Declined, Shareholder Venor Capital Management LP Decreased Holding by $577,600; Salesforce Com (CRM) Position Has Increased by Fukoku Mutual Life Insurance Company
Jeffrey Bersh decreased its stake in Westmoreland Coal Co (WLB) by 31.2% based on its latest 2017Q3 regulatory filing with ...
Auris Medical Holding AG (EARS) Reaches $0.28 52 Week Low; Coho Partners LTD Lowered Its Amerisourcebergen Corp. (ABC) Position
The stock of Auris Medical Holding AG (NASDAQ:EARS) hit a new 52-week low and has $0.25 target or 8.00% below ...
Alba Mineral Resources PLC (LON:ALBA) Stock Rating Reiterated by Analysts at First Equity; The GBX 6.00 Target Indicates 1,478.95% Potential; RCM Technologies (RCMT) Sentiment Is 0.89
RCM Technologies, Inc. provides business and technology solutions to the commercial and government sectors in the United States, Canada, and ...
EPS for Eyegate Pharmaceuticals, Inc. (EYEG) Expected At $-0.26; Katy Industries (KT) Sentiment Is 1.86
Analysts expect Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) to report $-0.26 EPS on February, 22.They anticipate $0.12 EPS change or 31.58% from ...
InVivo Therapeutics Holdings Corp. (NVIV) Reaches $0.52 52-Week Low; Last Week Medifast, Inc. (MED) Coverage
Among 3 analysts covering Medifast (NYSE:MED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Medifast ...
